Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL23150549

FC(F)(F)c1ccc(COC2CNC2)c(Cl)c1.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.49
SLC6A4 P31645 5/20 0.44
HTR2C P28335 1/20 0.41
HTR2B P41595 1/20 0.41
P2RX7 Q99572 1/20 0.39
MRGPRX4 Q96LA9 6/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
SLC6A2 P23975 1/20 0.39
CYP2C19 P33261 1/20 0.39
SLC6A3 Q01959 1/20 0.39
FFAR1 O14842 2/20 0.39
DAO P14920 1/20 0.39
PIM1 P11309 1/20 0.38
PDGFRA P16234 1/20 0.38
S1PR1 P21453 1/20 0.38
S1PR5 Q9H228 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29511836 0.91 SLC6A4 (0.50) MGLLSLC6A4HTR2CHTR2BDAO
Trifluoroacetic Acid SCHEMBL23152297 0.87 IDO1 (0.47) MGLLSLC6A4HTR2CHTR2BSLC6A2
Trifluoroacetic Acid SCHEMBL30945211 0.84 IDO1 (0.47) SLC6A4HTR2CHTR2BMRGPRX4FFAR4
Trifluoroacetic Acid SCHEMBL25325427 0.84 SLC6A4 (0.45) SLC6A4HTR2CHTR2BFFAR1FFAR4
SCHEMBL23148926 0.81 MGLL (0.51) MGLLMRGPRX4PIM1PDGFRAS1PR1
Trifluoroacetic Acid SCHEMBL30945234 0.80 SLC6A4 (0.42) MGLLSLC6A4P2RX7CYP1A2CYP3A4
Trifluoroacetic Acid SCHEMBL21722954 0.79 SLC6A4 (0.52) SLC6A4HTR2CHTR2BFFAR1
SCHEMBL30700754 0.79 SLC6A4 (0.46) MGLLSLC6A4HTR2CHTR2BMRGPRX4
Trifluoroacetic Acid SCHEMBL23091759 0.78 MGLL (0.43) MGLLSLC6A4P2RX7CYP1A2CYP3A4
Trifluoroacetic Acid SCHEMBL23091803 0.78 NAAA (0.43) MGLLSLC6A4HTR2CHTR2BSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210094972-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2021-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210094972-A1 HETEROCYCLIC COMPOUNDS CYP1B1, CYP4B1, CYP1A1 MGLL 2162/4885SLC6A4 4083/4885HTR2C 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.